Annual Drug Patent Expirations for ISENTRESS+HD Isentress Hd is a drug marketed by Msd Sub Merck and is included in one NDA. It is available from nine suppliers. There are…
Source
New patent expiration for Msd Sub drug ISENTRESS HD Read Post »
Annual Drug Patent Expirations for DUTREBIS Dutrebis is a drug marketed by Merck Sharp Dohme and is included in one NDA. There are two patents protecting this drug. The generic…
Source
New patent expiration for Merck Sharp drug DUTREBIS Read Post »
Annual Drug Patent Expirations for ISENTRESS Isentress is a drug marketed by Msd Sub Merck and is included in three NDAs. It is available from nine suppliers. There are six…
Source
New patent expiration for Msd Sub drug ISENTRESS Read Post »
Annual Drug Patent Expirations for KYNMOBI Kynmobi is a drug marketed by Sumitomo Pharma Am and is included in one NDA. There are fourteen patents protecting this drug. Drug patent…
Source
New patent expiration for Sumitomo Pharma drug KYNMOBI Read Post »
Annual Drug Patent Expirations for SYMPAZAN Sympazan is a drug marketed by Otter Pharms and is included in one NDA. It is available from one supplier. There are three patents…
Source
New patent expiration for Otter Pharms drug SYMPAZAN Read Post »
Annual Drug Patent Expirations for EXSERVAN Exservan is a drug marketed by Aquestive and is included in one NDA. It is available from one supplier. There are two patents protecting…
Source
New patent expiration for Aquestive drug EXSERVAN Read Post »
Annual Drug Patent Expirations for SUBOXONE Suboxone is a drug marketed by Indivior and is included in two NDAs. It is available from one supplier. There are four patents protecting…
Source
New patent expiration for Indivior drug SUBOXONE Read Post »
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPatentWatch.com
Source
New tentative approval for MYLAN drug efavirenz, emtricitabine and tenofovir alafenamide Read Post »
This chart shows the pharmaceutical companies with the most patents in Brazil. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
Source
Which pharmaceutical companies have the most drug patents in Brazil? Read Post »
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPatentWatch.com
Source
New tentative approval for MYLAN drug efavirenz, emtricitabine and tenofovir alafenamide Read Post »
Get new actionable insights and updates from BiotechBlog
